CUE-102
25-023
Phase 1 mab active
Quick answer
CUE-102 for Recurrent Glioblastoma is a Phase 1 program (mab) at Cue Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cue Biopharma
- Indication
- Recurrent Glioblastoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active